Genmab A (GMAB) Treasury Shares (2025)

Genmab A's (GMAB) quarterly Treasury Shares came in at $2.6 million in Q4 2025.

Genmab A (GMAB) Treasury Shares (2025) Analysis & Trends

Genmab A (GMAB) has 1 years of Treasury Shares data on file, last reported at $2.6 million in Q4 2025.

Quarterly Treasury Shares changed N/A year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.6 million (changed N/A YoY) and the FY2025 annual result came in at $2.6 million, changed N/A from the prior year.
Treasury Shares steadied at $2.6 million in Q4 2025.
In the past five years, Treasury Shares ranged from a high of $2.6 million in Q4 2025 to a low of $2.6 million in Q4 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Genmab A	2.05 Bn	548.77 Mn	1.07 Bn	-

Historic Data

Download Data

Date	Value
Dec 31, 2025	2.62 Mn
Dec 31, 2025	2.62 Mn